These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 25176558)

  • 1. Cardiovascular disease prevention.
    Van Camp G
    Acta Clin Belg; 2014 Dec; 69(6):407-11. PubMed ID: 25176558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secondary prevention in the clinical management of patients with cardiovascular diseases. Core components, standards and outcome measures for referral and delivery: a policy statement from the cardiac rehabilitation section of the European Association for Cardiovascular Prevention & Rehabilitation. Endorsed by the Committee for Practice Guidelines of the European Society of Cardiology.
    Piepoli MF; Corrà U; Adamopoulos S; Benzer W; Bjarnason-Wehrens B; Cupples M; Dendale P; Doherty P; Gaita D; Höfer S; McGee H; Mendes M; Niebauer J; Pogosova N; Garcia-Porrero E; Rauch B; Schmid JP; Giannuzzi P
    Eur J Prev Cardiol; 2014 Jun; 21(6):664-81. PubMed ID: 22718797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries.
    Kotseva K; Wood D; De Backer G; De Bacquer D; Pyörälä K; Keil U;
    Lancet; 2009 Mar; 373(9667):929-40. PubMed ID: 19286092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): the Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts).
    ; ; ; ; ; ; ; ; ; ; ; ; ;
    Eur J Prev Cardiol; 2012 Aug; 19(4):585-667. PubMed ID: 22763626
    [No Abstract]   [Full Text] [Related]  

  • 5. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts).
    Graham I; Atar D; Borch-Johnsen K; Boysen G; Burell G; Cifkova R; Dallongeville J; De Backer G; Ebrahim S; Gjelsvik B; Herrmann-Lingen C; Hoes A; Humphries S; Knapton M; Perk J; Priori SG; Pyorala K; Reiner Z; Ruilope L; Sans-Menendez S; Op Reimer WS; Weissberg P; Wood D; Yarnell J; Zamorano JL; Walma E; Fitzgerald T; Cooney MT; Dudina A; Vahanian A; Camm J; De Caterina R; Dean V; Dickstein K; Funck-Brentano C; Filippatos G; Hellemans I; Kristensen SD; McGregor K; Sechtem U; Silber S; Tendera M; Widimsky P; Zamorano JL; Altiner A; Bonora E; Durrington PN; Fagard R; Giampaoli S; Hemingway H; Hakansson J; Kjeldsen SE; Larsen ML; Mancia G; Manolis AJ; Orth-Gomer K; Pedersen T; Rayner M; Ryden L; Sammut M; Schneiderman N; Stalenhoef AF; Tokgözoglu L; Wiklund O; Zampelas A; ; ; ; ; ; ; ; ; ;
    Eur J Cardiovasc Prev Rehabil; 2007 Sep; 14 Suppl 2():E1-40. PubMed ID: 17726406
    [No Abstract]   [Full Text] [Related]  

  • 6. The challenge of cardiovascular prevention in primary care: implications of a European observational study in 8928 patients at different risk levels.
    Ludt S; Wensing M; Campbell SM; Ose D; van Lieshout J; Rochon J; Uhlmann L; Szecsenyi J
    Eur J Prev Cardiol; 2014 Feb; 21(2):203-13. PubMed ID: 23000862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Worksite health and wellness in the European union.
    Guazzi M; Faggiano P; Mureddu GF; Faden G; Niebauer J; Temporelli PL
    Prog Cardiovasc Dis; 2014; 56(5):508-14. PubMed ID: 24607015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [European practice guidelines on prevention of cardiovascular diseases: executive summary].
    Graham I; Atar D; Borch-Johnsen K; Boysen G; Burell G; Cifkova R; Dallongeville J; De Backer G; Ebrahim S; Gjelsvik B; Herrmann-Lingen C; Hoes A; Humphries S; Knapton M; Perk J; Priori SG; Pyorala K; Reiner Z; Ruilope L; Sans-Menendez S; Reimer WS; Weissberg P; Wood D; Yarnell J; Zamorano JL; ;
    G Ital Cardiol (Rome); 2008 Jan; 9(1):11-59. PubMed ID: 18383763
    [No Abstract]   [Full Text] [Related]  

  • 9. EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross-sectional survey in 12 European countries.
    Kotseva K; Wood D; De Backer G; De Bacquer D; Pyörälä K; Reiner Z; Keil U;
    Eur J Cardiovasc Prev Rehabil; 2010 Oct; 17(5):530-40. PubMed ID: 20577089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk prediction tools in cardiovascular disease prevention: A report from the ESC Prevention of CVD Programme led by the European Association of Preventive Cardiology (EAPC) in collaboration with the Acute Cardiovascular Care Association (ACCA) and the Association of Cardiovascular Nursing and Allied Professions (ACNAP).
    Rossello X; Dorresteijn JA; Janssen A; Lambrinou E; Scherrenberg M; Bonnefoy-Cudraz E; Cobain M; Piepoli MF; Visseren FL; Dendale P
    Eur Heart J Acute Cardiovasc Care; 2020 Aug; 9(5):522-532. PubMed ID: 31303009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Year in Cardiology 2013: cardiovascular disease prevention.
    Gielen S; Landmesser U
    Eur Heart J; 2014 Feb; 35(5):307-12. PubMed ID: 24385374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence supporting primary prevention of cardiovascular diseases with statins: Gaps between updated clinical results and actual practice.
    Bruckert E; Ferrières J
    Arch Cardiovasc Dis; 2014 Mar; 107(3):188-200. PubMed ID: 24613429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of a Multidrug Pill In Reducing cardiovascular Events (UMPIRE): rationale and design of a randomised controlled trial of a cardiovascular preventive polypill-based strategy in India and Europe.
    Thom S; Field J; Poulter N; Patel A; Prabhakaran D; Stanton A; Grobbee DE; Bots ML; Reddy KS; Cidambi R; Rodgers A
    Eur J Prev Cardiol; 2014 Feb; 21(2):252-61. PubMed ID: 23038750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors impeding the implementation of cardiovascular prevention guidelines: findings from a survey conducted by the European Society of Cardiology.
    Graham IM; Stewart M; Hertog MG;
    Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):839-45. PubMed ID: 17001227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. European Society of Cardiology guidelines: preoperative cardiac risk assessment and perioperative cardiac management in noncardiac surgery.
    Kristensen SD
    J Cardiovasc Med (Hagerstown); 2011 Mar; 12(3):226. PubMed ID: 21285739
    [No Abstract]   [Full Text] [Related]  

  • 16. [Spanish Interdisciplinary Committee for Cardiovascular Disease Prevention and the Spanish Society of Cardiology position statement on dyslipidemia management. Differences between the European and American guidelines].
    Lobos Bejarano JM; Galve E; Royo-Bordonada MÁ; Alegría Ezquerra E; Armario P; Brotons Cuixart C; Camafort Babkowski M; Cordero Fort A; Maiques Galán A; Mantilla Morató T; Pérez Pérez A; Pedro-Botet J; Villar Álvarez F; González-Juanatey JR;
    Clin Investig Arterioscler; 2015; 27(1):36-44. PubMed ID: 25444651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Secondary prevention in the clinical management of patients with cardiovascular diseases. Core components, standards and outcome measures for referral and delivery].
    Cardiac Rehabilitation Section of the European Association for Cardiovascular Prevention & Rehabilitation
    Kardiologiia; 2014; 54(11):87-104. PubMed ID: 25902665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary prevention of cardiovascular diseases by lipid-lowering treatment in German general practice: results from GPs ignoring guidelines and risk calculators.
    Oriol-Zerbe C; Abholz HH
    Eur J Gen Pract; 2007; 13(1):27-34. PubMed ID: 17366291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk stratification in cardiovascular disease primary prevention - scoring systems, novel markers, and imaging techniques.
    Zannad F; De Backer G; Graham I; Lorenz M; Mancia G; Morrow DA; Reiner Z; Koenig W; Dallongeville J; Macfadyen RJ; Ruilope LM; Wilhelmsen L;
    Fundam Clin Pharmacol; 2012 Apr; 26(2):163-74. PubMed ID: 22220636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspirin therapy in primary cardiovascular disease prevention: a position paper of the European Society of Cardiology working group on thrombosis.
    Halvorsen S; Andreotti F; ten Berg JM; Cattaneo M; Coccheri S; Marchioli R; Morais J; Verheugt FW; De Caterina R
    J Am Coll Cardiol; 2014 Jul; 64(3):319-27. PubMed ID: 25034070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.